These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32031415)

  • 1. A Novel and Easy Method to Locate and Remove First Approved Long-Term Implantable Glucose Sensors.
    Akturk HK; Brackett S
    Diabetes Technol Ther; 2020 Jul; 22(7):538-540. PubMed ID: 32031415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisite Study of an Implanted Continuous Glucose Sensor Over 90 Days in Patients With Diabetes Mellitus.
    Dehennis A; Mortellaro MA; Ioacara S
    J Diabetes Sci Technol; 2015 Jul; 9(5):951-6. PubMed ID: 26224762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System.
    Deiss D; Szadkowska A; Gordon D; Mallipedhi A; Schütz-Fuhrmann I; Aguilera E; Ringsell C; De Block C; Irace C
    Diabetes Technol Ther; 2019 May; 21(5):254-264. PubMed ID: 31021180
    [No Abstract]   [Full Text] [Related]  

  • 4. A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study.
    Christiansen MP; Klaff LJ; Bailey TS; Brazg R; Carlson G; Tweden KS
    Diabetes Technol Ther; 2019 May; 21(5):231-237. PubMed ID: 30925083
    [No Abstract]   [Full Text] [Related]  

  • 5. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
    Christiansen MP; Klaff LJ; Brazg R; Chang AR; Levy CJ; Lam D; Denham DS; Atiee G; Bode BW; Walters SJ; Kelley L; Bailey TS
    Diabetes Technol Ther; 2018 Mar; 20(3):197-206. PubMed ID: 29381090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
    Garg SK; Liljenquist D; Bode B; Christiansen MP; Bailey TS; Brazg RL; Denham DS; Chang AR; Akturk HK; Dehennis A; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2022 Feb; 24(2):84-92. PubMed ID: 34515521
    [No Abstract]   [Full Text] [Related]  

  • 7. Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
    Tweden KS; Deiss D; Rastogi R; Addaguduru S; Kaufman FR
    Diabetes Technol Ther; 2020 May; 22(5):422-427. PubMed ID: 31697182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local release of masitinib alters in vivo implantable continuous glucose sensor performance.
    Avula M; Jones D; Rao AN; McClain D; McGill LD; Grainger DW; Solzbacher F
    Biosens Bioelectron; 2016 Mar; 77():149-56. PubMed ID: 26402593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor.
    Sanchez P; Ghosh-Dastidar S; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2019 Dec; 21(12):677-681. PubMed ID: 31385732
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-Term Home Study on Nocturnal Hypoglycemic Alarms Using a New Fully Implantable Continuous Glucose Monitoring System in Type 1 Diabetes.
    Wang X; Ioacara S; DeHennis A
    Diabetes Technol Ther; 2015 Nov; 17(11):780-6. PubMed ID: 26177299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the Long-Term Implantable Senseonics Continuous Glucose Monitoring System and Other Continuous Glucose Monitoring Systems.
    Joseph JI
    J Diabetes Sci Technol; 2021 Jan; 15(1):167-173. PubMed ID: 32345047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance characterization of an abiotic and fluorescent-based continuous glucose monitoring system in patients with type 1 diabetes.
    Mortellaro M; DeHennis A
    Biosens Bioelectron; 2014 Nov; 61():227-31. PubMed ID: 24906080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy.
    Irace C; Cutruzzolà A; Tweden K; Kaufman FR
    Expert Rev Med Devices; 2021 Oct; 18(10):909-914. PubMed ID: 34528851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System.
    Lorenz C; Sandoval W; Mortellaro M
    Diabetes Technol Ther; 2018 May; 20(5):344-352. PubMed ID: 29600877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.
    Kropff J; Choudhary P; Neupane S; Barnard K; Bain SC; Kapitza C; Forst T; Link M; Dehennis A; DeVries JH
    Diabetes Care; 2017 Jan; 40(1):63-68. PubMed ID: 27815290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subcutaneously implantable glucose sensors in patients with diabetes mellitus; still many problems].
    Gerritsen M; Jansen JA; Lutterman JA
    Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1313-6. PubMed ID: 12148218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of Implantable Continuous Glucose Monitoring Sensor.
    Barnard KD; Kropff J; Choudhary P; Neupane S; Bain SC; Kapitza C; Forst T; Link M; Mdingi C; DeVries JH
    J Diabetes Sci Technol; 2018 May; 12(3):634-638. PubMed ID: 28990436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes.
    Wadwa RP; Laffel LM; Shah VN; Garg SK
    Diabetes Technol Ther; 2018 Jun; 20(6):395-402. PubMed ID: 29901421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine model of implantable glucose sensors: a novel model for glucose sensor development.
    Klueh U; Kreutzer DL
    Diabetes Technol Ther; 2005 Oct; 7(5):727-37; discussion 738-40. PubMed ID: 16241876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards smart tattoos: implantable biosensors for continuous glucose monitoring.
    Heo YJ; Takeuchi S
    Adv Healthc Mater; 2013 Jan; 2(1):43-56. PubMed ID: 23184404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.